Drug
Samarium Sm-153 lexidronam clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Other names
- 153Sm-EDTMP
- 1
Studies by the year they started
3 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
M.D. Anderson Cancer Center (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Cytogen Corporation (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Analgesics, Non-Narcotic source
- One of Radiopharmaceuticals source
Studies
Open first, then newest update. How each study uses samarium Sm-153 lexidronam is read from its arms, and is right about nine times in ten.
Testing it · 3
- Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk OsteosarcomaTerminatedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT01886105Written as Sm-EDTMP
- Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only MetastasesCompletedPhase 2M.D. Anderson Cancer CenterNCT00429507Written as 153 Sm-EDTMP
- Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate CancerStatus unknownPhase 1/2Cytogen CorporationNCT00121095Written as Samarium Sm-153 lexidronam + Docetaxel
Codes
What other systems call samarium Sm-153 lexidronam · ClinicalTrials.gg INT003473
- MeSH (NLM) C061972samarium Sm-153 lexidronamConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 745X144DZYSAMARIUM SM-153 LEXIDRONAMConfirmed FDA, NLM
- RxNorm 177906One source FDA
- NCI Thesaurus C152291Samarium Sm-153 LexidronamOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C061972 | samarium Sm-153 lexidronam | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 745X144DZY | SAMARIUM SM-153 LEXIDRONAM | Confirmed FDA, NLM |
| RxNorm | 177906 | — | One source FDA |
| NCI Thesaurus | C152291 | Samarium Sm-153 Lexidronam | One source FDA |
Also registered as samarium sm-153 lexidronam pentasodium (UNII 7389YR3OOV · RxNorm 317675).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.